KDM5B-IN-4
KDM5B-IN-4 (compound 11ad) is a lysine demethylase 5B (KDM5B) inhibitor with an IC50 of 0.025 μM KDM5B-IN-4 increases substrate H3K4me1/2/3 level by inhibiting KDM5B in PC-3 cells. KDM5B-IN-4 downregulates PI3K/AKT. KDM5B-IN-4 reduces tumor volume in mice and shows less toxic to organs[1].
Product Specifications
UNSPSC
12352005
Target
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kdm5b-in-4.html
Purity
99.68
Solubility
DMSO : 33.33 mg/mL (ultrasonic; adjust pH to 2 with 1 M HCl)
Smiles
CN1CCN(CC1)CCNC(C2=CC(C3=CC=C4C=CC=CC4=C3)=NC5=C2C=NN5C6=CC=CC=C6)=O
Molecular Formula
C30H30N6O
Molecular Weight
490.60
References & Citations
[1]Cao Y, et al. Discovery of a novel 1H-pyrazole- [3,4-b] pyridine-based lysine demethylase 5B inhibitor with potential anti-prostate cancer activity that perturbs the phosphoinositide 3-kinase/AKT pathway. Eur J Med Chem. 2023 May 5;251:115250.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY424093 100 µg
C1ORF95 (STUM) (NM_001003665) Human Over-expression Lysate
Sign In for Pricing
View Details 
![5H,6H,7H,8H-Imidazo[1,2-a]pyridine-3-sulfonyl Chloride (~85%)](https://cdn.genprice.uk/products/572/3138520516367/imageurl/trc-h325683-50mg.webp)
TRC-H325683-50MG 50 mg
5H,6H,7H,8H-Imidazo[1,2-a]pyridine-3-sulfonyl Chloride (~85%)
Sign In for Pricing
View Details 
